Tier 3 reports for 'BUPIVACAINE HYDROCHLORIDE' and 'solution'
Tier 3 Drug Shortages
7 reports found
| Brand name | Company Name | Date Updated | Strength(s) | Status | Report ID |
|---|---|---|---|---|---|
| MARCAINE E | PFIZER CANADA ULC | 2024-04-18 | 0.182MG 50MG | Actual shortage | 207832 |
| BUPIVACAINE INJECTION BP | STERIMAX INC | 2024-04-14 | 2.5MG | Actual shortage | 213681 |
| BUPIVACAINE HYDROCHLORIDE INJECTION, USP | BAXTER CORPORATION | 2024-04-11 | 7.5MG | Avoided shortage | 210780 |
| BUPIVACAINE INJECTION BP | STERIMAX INC | 2024-04-05 | 2.5MG | Anticipated shortage | 213678 |
| BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP | STERIMAX INC | 2024-03-08 | 7.5MG | Avoided shortage | 211218 |
| SENSORCAINE | ASPEN PHARMACARE CANADA INC. | 2024-02-07 | 5MG | Resolved | 209399 |
| SENSORCAINE WITH EPINEPHRINE | ASPEN PHARMACARE CANADA INC. | 2024-02-07 | 2.5MG 5MCG | Resolved | 203898 |
Showing 1 to 7 of 7
Tier 3 Drug Discontinuations
0 reports found
| Brand name | Company Name | Date Updated | Strength(s) | Status | Report ID |
|---|
Showing 1 to 0 of 0